Research Article

Prognostic Impact of Hypoxia-Inducible miRNA-210 in Patients with Lung Adenocarcinoma

Table 2

Relationship between miR-210 expression and clinical characteristics.

Clinical characteristicsmiR-210 expression
Ad casesSq cases

Gender0.0861.000
 Male2.32 ± 2.892.88 ± 2.00
 Female1.45 ± 1.672.93 ± 0.88
Age0.029
 ≤651.18 ± 1.71
 ≥662.17 ± 2.602.87 ± 1.89
Tumor size0.4021.000
 <30 mm1.84 ± 1.952.87 ± 1.62
 ≥30 mm1.87 ± 2.983.25 ± 2.14
Histology
 Adeno1.86 ± 2.40
 Squamous2.87 ± 1.89
T factor0.4171.000
 T1-T21.82 ± 2.482.88 ± 1.65
 T3-T42.34 ± 1.703.37 ± 4.40
Lymph node0.034
 Negative1.44 ± 2.012.87 ± 1.89
 Positive2.34 ± 2.97
P-stage0.0191.000
 Stage I1.37 ± 2.022.88 ± 1.65
 Stages II-III2.62 ± 2.773.37 ± 4.40
ly factor0.0250.620
 Negative1.23 ± 1.443.30 ± 2.07
 Positive2.24 ± 2.842.09 ± 1.23
v factor0.0971.000
 Negative1.75 ± 1.972.12 ± 1.84
 Positive2.34 ± 2.983.01 ± 1.86
Relapse0.0071.000
 With2.72 ± 2.632.88 ± 1.96
 Without1.35 ± 1.752.87 ± 1.84

Ad: adenocarcinoma.
Sq: squamous cell carcinoma.
Relapse was defined as first evidence of radiographic metastatic disease after surgery.
< 0.05.